Betaliq, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.betaliq.com
Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension
Phase 2
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2021-06-02
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Betaliq, Inc.
- Target Recruit Count
- 226
- Registration Number
- NCT04910100
- Locations
- 🇺🇸
Site 0012, Newport Beach, California, United States
© Copyright 2025. All Rights Reserved by MedPath